Medlinker
Medlinker
Medical Alliance is a post of physician social service platform.
Medlinker, founded in June, 2014 and headquartered in Chengdu, is a chronic disease management platform. Established by Wang Shirui, the company has received financings from Sensegain Asset Management, Sequoia Capital China Fund, China Capital Zhongcai Fund Management and so on. Rivals that have direct and indirect competition with Medlinker globally include Duodianyun, etc.
- All
- News
- Analysis
- Research
Briefing Feb 21, 2023 11:10 AM
· Healthcare
We-Linking Raised Over CNY 10 Mn in Angel Round
Briefing Feb 21, 2023 10:07 AM
· Healthcare
Intraoperative Neurophysiological Monitoring Equipment Developer NeuroFlag Closed An Angel Round
In-depth
Briefing Feb 16, 2023 12:51 PM
· Healthcare
Innovative Drug Developer Rezu Bio Raised CNY 10 Mn in Series Pre-A
Briefing Feb 15, 2023 12:32 PM
· Healthcare
ZD Medtech Raised Over CNY 100 Mn in Series B
Nov 16, 2022 05:19 PM
Nov 07, 2022 04:27 PM
Aug 29, 2022 05:45 PM
Apr 18, 2022 06:30 PM
Briefing Feb 13, 2023 12:54 PM
· Healthcare
Smart Powered Bionic Prosthetic Star BionicM Nets Over CNY 10 Mn
Briefing Feb 08, 2023 11:44 AM
· Healthcare
Medical Technology Company MacroLux Nets Nearly CNY 100 Mn in Series A
Briefing Feb 07, 2023 12:11 PM
· Healthcare
ForLong Biotech Nets Over CNY 100 Mn in Series A
Briefing Feb 07, 2023 10:59 AM
· Healthcare
CytoCan Corp. Nets CNY 10 Mn in Seed Round
Briefing Jan 31, 2023 11:02 AM
· Healthcare
Fine Vision Completes Angel Financing Round Worth Nearly CNY 50 Mn
Briefing Jan 30, 2023 10:44 AM
· Healthcare
Levostar Completes Pre-A Financing Round to Further Invest in CGT
Briefing Jan 28, 2023 11:20 AM
· Healthcare
YingHe Neuro Raises Over CNY 100 Mn in Angel Round
Healthcare · Analysis
How the Hospital Ecosystem of Medlinker is Shaping the Future of China's Healthcare
Actually, it is a huge market to dig into a particular disease. For example, the company had collaborated with Gilead Science, a research-based biopharmaceutical company focused on innovative medicines, in exploring and developing DTP(Direct To Patient) solutions of Hepatitis C.
Nov 22, 2018 11:30 PM
Briefing Jan 18, 2023 10:59 AM
· Healthcare
BlissBio Nets Over CNY 100 Mn in Series B+
Briefing Jan 17, 2023 10:36 AM
· Healthcare
Medical Equipment Company PowerSite Nets Over CNY 100 Mn in Series B
Briefing Jan 13, 2023 11:03 AM
· Healthcare
Equipment Company Keyto Nets Over CNY 100 Mn in Series C
Briefing Jan 12, 2023 10:53 AM
· Healthcare
IVD Company Bioantibody Nets Over CNY 100 Mn in Series A
See more
Related Companies
EqualOcean Analysis
- IntoCare Zhang Hui: Ingenuity Forges Quality, Continuous Improvement Safeguards Lives
- Robo CT Partner Wang Xiaoqi: Winning the International Stage with Manufacturing Excellence
- EqualOcean | Southern Weekly 2022 'China Greenwashing List'
- EqualOcean｜China's Top 20 ESG Performers Among Private Enterprises（Part III）
- Pure Global: The International Engine of Medical Technology Globalization